Randomized trial demonstrates that IL-11 constrains energy expenditure in beige adipocytes, suggesting a novel obesity treatment target.
Adipocytes exhibit cellular plasticity by secreting pro-inflammatory cytokines in response to an energy excess. Here, we identify that interleukin (IL)-11 is robustly induced and secreted from adipocytes, especially beige adipocytes upon adrenergic stimulation. IL-11 inhibits adipocyte thermogenesis through binding to IL-11 receptor a (IL-11Ra) and serves as a “brake” to maintain energy homeostasis. Adipocyte-specific IL-11Ra-knockout mice exhibit enhanced whole-body energy consumption and improved glucose and lipid metabolism under a high-fat diet (HFD). Inhibition of IL-11/IL-11Ra signaling enhances sphingosine kinase 1 (Sphk1)-driven production of sphingosine-1-phosphate (S1P), thus remodeling intracellular calcium cycling in beige adipocytes. Notably, treatment with a designed peptide against IL-11Ra in obese mice effectively alleviates fat accumulation and obesity-associated disorders. Taken together, our study defines a physiological and noncanonical mechanism of beige adipocyte-derived IL-11 in energy metabolism, which may serve as a promising target for the treatment of obesity. • IL-11 is an adipokine whose secretion is triggered by energy stress • IL-11 serves as a brake to limit energy overconsumption via IL-11Ra • IL-11/IL-11Ra inhibits Sphk1 and thus S1P production in beige adipocytes • IL-11Ra deficiency enhances thermogenesis and mitigates obesity Liu et al. identify that beige adipocyte-derived IL-11 inhibits energy expenditure by remodeling sphingolipid metabolism via binding to IL-11Ra. Inhibition of IL-11/IL-11Ra signaling promotes Sphk1-driven production of S1P, enhances mitochondrial function, and contributes to systemic metabolic benefits.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: